These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 23499841

  • 1. The oxidative stress in breast tumors of postmenopausal women is ERα/ERβ ratio dependent.
    Sastre-Serra J, Nadal-Serrano M, Pons DG, Valle A, Garau I, García-Bonafé M, Oliver J, Roca P.
    Free Radic Biol Med; 2013 Aug; 61():11-7. PubMed ID: 23499841
    [Abstract] [Full Text] [Related]

  • 2. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
    Nadal-Serrano M, Pons DG, Sastre-Serra J, Blanquer-Rosselló Mdel M, Roca P, Oliver J.
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
    [Abstract] [Full Text] [Related]

  • 3. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.
    Nadal-Serrano M, Sastre-Serra J, Pons DG, Miró AM, Oliver J, Roca P.
    J Cell Biochem; 2012 Oct; 113(10):3178-85. PubMed ID: 22615145
    [Abstract] [Full Text] [Related]

  • 4. Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women.
    Christian RC, Liu PY, Harrington S, Ruan M, Miller VM, Fitzpatrick LA.
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2713-20. PubMed ID: 16608893
    [Abstract] [Full Text] [Related]

  • 5. 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio.
    Miró AM, Sastre-Serra J, Pons DG, Valle A, Roca P, Oliver J.
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):133-9. PubMed ID: 21172438
    [Abstract] [Full Text] [Related]

  • 6. Expression of estrogen receptor alpha and estrogen receptor beta in fine needle aspirates of breast carcinoma.
    Kapila K, Anim JT, Francis IM, Al-Mulla F, George SS, Behbehani AI.
    Acta Cytol; 2010 Feb; 54(1):25-30. PubMed ID: 20306984
    [Abstract] [Full Text] [Related]

  • 7. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
    Bièche I, Parfait B, Laurendeau I, Girault I, Vidaud M, Lidereau R.
    Oncogene; 2001 Dec 06; 20(56):8109-15. PubMed ID: 11781824
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep 06; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 9. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
    Evers NM, van de Klundert TM, van Aesch YM, Wang S, de Roos WK, Romano A, de Haan LH, Murk AJ, Ederveen AG, Rietjens IM, Groten JP.
    Toxicol In Vitro; 2013 Sep 06; 27(6):1753-61. PubMed ID: 23680332
    [Abstract] [Full Text] [Related]

  • 10. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 06; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 11. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
    Bozkurt KK, Kapucuoğlu N.
    Pathol Res Pract; 2012 Mar 15; 208(3):133-9. PubMed ID: 22336175
    [Abstract] [Full Text] [Related]

  • 12. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, Zheng Y, Ye Q.
    Biochim Biophys Acta; 2008 Jun 15; 1783(6):1220-8. PubMed ID: 18302941
    [Abstract] [Full Text] [Related]

  • 13. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
    Skliris GP, Leygue E, Watson PH, Murphy LC.
    J Steroid Biochem Mol Biol; 2008 Mar 15; 109(1-2):1-10. PubMed ID: 18243688
    [Abstract] [Full Text] [Related]

  • 14. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.
    Sotoca AM, Ratman D, van der Saag P, Ström A, Gustafsson JA, Vervoort J, Rietjens IM, Murk AJ.
    J Steroid Biochem Mol Biol; 2008 Dec 15; 112(4-5):171-8. PubMed ID: 18955141
    [Abstract] [Full Text] [Related]

  • 15. Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women.
    Sakaguchi H, Fujimoto J, Aoki I, Tamaya T.
    Steroids; 2003 Jan 15; 68(1):11-9. PubMed ID: 12475719
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Edén P, Peterson C, Malmström P, Isola J, Borg A, Fernö M.
    Clin Cancer Res; 2007 Apr 01; 13(7):1987-94. PubMed ID: 17404078
    [Abstract] [Full Text] [Related]

  • 17. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP.
    Cancer; 2006 Jun 15; 106(12):2610-6. PubMed ID: 16700038
    [Abstract] [Full Text] [Related]

  • 18. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
    Pons DG, Torrens-Mas M, Nadal-Serrano M, Sastre-Serra J, Roca P, Oliver J.
    Int J Biochem Cell Biol; 2015 Sep 15; 66():85-94. PubMed ID: 26232188
    [Abstract] [Full Text] [Related]

  • 19. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.
    Mol Endocrinol; 2006 Dec 15; 20(12):3070-82. PubMed ID: 16901971
    [Abstract] [Full Text] [Related]

  • 20. Significance of ERβ expression in different molecular subtypes of breast cancer.
    Guo L, Meng J, Yilamu D, Jakulin A, Fu M, Wang B, Abulajiang G.
    Diagn Pathol; 2014 Jan 23; 9():20. PubMed ID: 24457087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.